THOMAS BENEDICT BRYAN, MD
Psychiatric at M St, Merced, CA
License number
California A300690
Category
Psychiatric
Type
Pain Medicine
Address
Address
3351 M St STE 120, Merced, CA 95348
Phone
(209) 383-5999
(209) 383-6888 (Fax)
(209) 383-6888 (Fax)
Professional information
Dr. Thomas B Bryan - MD (Doctor of Medicine)
Hospitals:
3351 M St STE 120, Merced 95348
Mercy Medical Center Merced
333 Mercy Ave, Merced 95340
3351 M St STE 120, Merced 95348
Mercy Medical Center Merced
333 Mercy Ave, Merced 95340
Mercy Medical Center Merced
333 Mercy Ave, Merced 95340
3351 M St STE 120, Merced 95348
Mercy Medical Center Merced
333 Mercy Ave, Merced 95340
Education:
Medical Schools
Royal College Of Surgeons In Ireland, National University Of Ireland, School Of Medicine
Royal College Of Surgeons In Ireland, National University Of Ireland, School Of Medicine
Medthod Of Treating A Systemic Inflammatory Disorder And Damaged Internal Tissues
US Patent:
2013012, May 16, 2013
Filed:
Nov 15, 2011
Appl. No.:
13/373445
Inventors:
Thomas Benedict Bryan - Merced CA, US
International Classification:
A61K 31/047, A61P 17/16, A61P 29/00, A61K 31/4172, A61P 37/00
US Classification:
514400, 514738
Abstract:
3% Glycerin plus 3% amino acids intravenously used for nutritional purposes produces a rapid remission of an acute exacerbation in Behcet's Disease. External manifestations such as oral, vulva, penile and skin lesions rapidly heal when Glycerin is added to the amino acids. While the disease process in Behcet's Disease is likely improved by amino acids alone, the robustness of the healing of open lesions and the overall well-being of the patient in acute exacerbations is greatly enhanced by the addition of 3% Glycerin to the IV fluid. IV 3% Glycerin and 3% Amino Acids also produced remissions in Myasthenia Gravis, Guillain-Barre Disease, and Chronic Inflammatory Demyelinating Polyneuropathy. 3% Glycerin with amino acids could cause healing in many autoimmune diseases and can help external and internal lesions to heal.Glycerin also prevents bacteria from forming a biofilm which in most infections is necessary for the bacteria to become pathologic.
Method Of Destroying Bacterial Biofilm Using Sterile Intravenous Or Intracavernous Glycerin
US Patent:
2014001, Jan 16, 2014
Filed:
Jun 6, 2013
Appl. No.:
13/912060
Inventors:
Thomas Bryan - Merced CA, US
International Classification:
A61K 31/047, A61K 9/00
US Classification:
514738
Abstract:
Disclosed is a method of preventing or inhibiting biofilm formation by a population of bacteria comprising the administration of a sterile intravenous normal saline solution containing glycerin and amino acids. In some embodiments, the concentration of glycerin in the normal saline solution is approximately 3%. In some embodiments, the concentration of amino acids in the normal saline solution is approximately 3%. In some embodiments, the intravenous solution is administered for 48 hours at 80 cc/hour. In some embodiments, the solution is infused via intracavernous administration into an infected body cavity.
Method Of Treating An Autoimmune Disorder
US Patent:
6103748, Aug 15, 2000
Filed:
Dec 29, 1998
Appl. No.:
9/223069
Inventors:
Thomas B. Bryan - Merced CA
International Classification:
A61K 31415, A61K 31195
US Classification:
514400
Abstract:
A method of administering an amino acid protocol intravenously for the treatment of a patient suffering from an autoimmune disease is provided.